Jasson Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.43 M
- Company Age 38 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.90 M
- Revenue Growth 22.21%
- Profit Growth 48.21%
- Ebitda 33.71%
- Net Worth -1.68%
- Total Assets 0.41%
About Jasson Pharma
Jasson Pharma Private Ltd. (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 1986 and has a history of 38 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.43 M.
The company currently has active open charges totaling ₹2.90 M.
Rajesh Jain and Nisha Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1986PTC026146
- Company No.
026146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 1986
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Jasson Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Jain  | Director | 10-Mar-2023 | Current |
| Nisha Jain | Director | 10-Mar-2023 | Current |
Financial Performance of Jasson Pharma.
Jasson Pharma Private Ltd., for the financial year ended 2016, experienced significant growth in revenue, with a 22.21% increase. The company also saw a substantial improvement in profitability, with a 48.21% increase in profit. The company's net worth dipped by a decrease of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jasson Pharma?
In 2017, Jasson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Devoe Reality Private LimitedRajesh Jain is a mutual person
- Knowhow Infra Private Limited
Rajesh Jain is a mutual person
Charges (Loans)
₹2.90 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.19 Cr
- The Haryana Financial Corporation : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 1989 | Punjab National Bank | ₹0.15 M | Open |
| 28 Dec 1989 | Punjab National Bank | ₹0.40 M | Open |
| 18 Dec 1989 | Punjab National Bank | ₹0.93 M | Open |
| 28 Dec 1988 | Punjab National Bank | ₹0.40 M | Open |
| 08 Jun 1988 | The Haryana Financial Corporation | ₹1.03 M | Open |
How Many Employees Work at Jasson Pharma?
Unlock and access historical data on people associated with Jasson Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jasson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jasson Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
